SOST and Alzheimer disease: In 2024, Jiang group discovered the molecular mechanism by which osteocyte-derived SOST regulates cognitive decline in AD through the WNT/β-catenin pathway.55 The study found that during aging and the progression of AD, osteocyte-derived SOST can cross the BBB in aged mice and bind to LPR6 receptors on neurons.